Background--Obesity is key feature of the metabolic syndrome and is associated with high cardiovascular morbidity and mortality. Obesity is associated with macrovascular endothelial dysfunction, a determinant of outcome in patients with coronary artery disease. Here, we compared the influence of obesity on microvascular endothelial function to that of established cardiovascular risk factors such as diabetes mellitus, hypertension, hypercholesterolemia, and smoking in patients with suspected coronary artery disease.
D
uring the past 3 decades, the prevalence of obesity has nearly doubled worldwide and is still increasing. 1 Obesity is closely related to the occurrence of glucose intolerance, high blood pressure, dyslipidemia, and also cardiovascular disease (CVD). Endothelial dysfunction is a well-known early step in the pathogenesis of CVD. 2, 3 Endothelial function plays an important role in the regulation of vascular tone, thrombosis, and smooth muscle cell proliferation and when impaired, it can initiate and accelerate progression of atherosclerosis. 4, 5 Endothelial function can be assessed with different methods that rely on the administration of stimuli of different vasodilator pathways such as mechanical stress, thermal provocation, electrical stimuli, or administration of vasoactive agents by iontophoresis. 6 A blunted response is indicative of endothelial dysfunction and predictive for CVD and clinical prognosis. [7] [8] [9] [10] Only recently, the cutaneous microcirculation has emerged as a clinically relevant model for microvascular reactivity and endothelial function. 6, 11 In the microcirculation of the skin, postocclusive reactive hyperemia triggers several pathways for vascular reactivity. In addition to endothelial nitric oxide synthase activity, sensory nerves and endothelium-derived hyperpolarizing factors play an important role in the vasomotor regulation of the microcirculation. 12 Laser Doppler flowmetry (LDF) is frequently used to measure changes in blood cell flow (flux) in the skin microcirculation after endothelial stimulation. 6 Recently, peripheral arterial tonometry (EndoPAT â ; Itamar Medical Ltd, Caesarea, Israel) has been developed to measure changes in pulse wave amplitude within the fingertip. 13 A new method to assess microvascular endothelial reactivity is digital thermal monitoring (DTM). By monitoring the digital skin temperature overshoot during hyperemia, vascular reactivity can be quantified. 14 In the current study we aimed to determine the influence of obesity on endothelial function compared with other components of the metabolic syndrome and smoking in a population of patients with suspected coronary artery disease. Endothelial function was assessed simultaneously by LDF, EndoPAT, and DTM, and its relationship to obesity as well as other clinical risk factors and baseline characteristics was analyzed.
Methods

Study Design and Population
The study design was previously published and primarily focused on the relationship between radial artery spasm and endothelial function. 15 In summary, patients at risk for coronary disease and referred for elective cardiac catheterization were eligible for study participation. Patients with STsegment elevation myocardial infarction or hemodynamic instability or renal disease with a glomerular filtration rate <30 were excluded. Also, patients with an intention to undergo transfemoral arterial access (ie, patients with coronary bypass grafts) were excluded. Between May 2014 and June 2015, patients were screened at the VU University Medical Center. After obtaining informed consent, baseline characteristics were noted. Also, a predefined set of established cardiovascular risk factors (diabetes mellitus, hypercholesterolemia, hypertension, body mass index [BMI] , age, smoking, and sex) and cardiovascular history, were registered. Thereafter, 3 different endothelial function tests were performed at the same time and subsequently all patients underwent coronary angiography. In this secondary analysis, the relationship between BMI, other known cardiovascular risk factors, and endothelial function was studied. The study protocol was approved by the local ethics committee and performed in accordance with the Declaration of Helsinki.
Endothelial Function Measurements
All endothelial function measurements were performed at the same time by trained researchers in a quiet and temperaturecontrolled room. The patients were resting during the entire measurement period of 15 minutes. To determine postocclusive reactive hyperemia, a blood pressure cuff was inflated at the upper arm to a pressure at least 30 mm Hg above the systolic arterial blood pressure. The microvascular measurements were started 5 minutes before the occlusion period and were stopped 5 minutes after the occlusion period (during postocclusive reactive hyperemia). The maximum hyperemic response is reached after 5 minutes of vascular occlusion. This time point is recommended for EndoPAT measurements. 16 
EndoPAT Measurements
The EndoPAT â device (Itamar Medical Ltd) was used to measure the arterial pulse wave amplitude with pneumatic probes placed on the index finger of each hand, capable of sensing volume changes in the digit with each arterial pulsation. The contralateral hand was used as a reference to correct for potential systemic changes. What Are the Clinical Implications?
• Body mass index strongly influences endothelial function throughout the spectrum of patients with and without treated metabolic risk factors.
• This study sheds light on the relation of endothelial function and the occurrence of metabolic disease in obese patients.
• Further studies are necessary to investigate the role of endothelial dysfunction as a predictor of outcome in patients with a high body mass index.
occluded side, divided by the same ratio of the (nonoccluded) control arm as a correction for possible systemic effects. 17 
Laser Doppler Flowmetry
Single-point LDF (Moor Instruments, Devon, UK) was measured at the upper phalanx of the right index finger. The signal was quantified as the product of average blood cell velocity and concentration. Because it does not provide an exact measure of flow (mL/min), flux is often used. 6 The flux was determined at baseline and the peak (5 minutes after cuff deflation). Peak minus baseline and the percentage increase between baseline and peak were calculated. This percentage was used as a measure of endothelial function.
Digital Thermal Monitoring
Continuous DTM was performed during the entire measurement of 15 minutes with the GOBI-1417 camera (XenICs NV, Leuven, Belgium) at the distal phalanx of the thumb and the proximal phalanx of the index finger (D2). DTM data were expressed in temperature rebound (peak temperature minus baseline temperature) compared with baseline temperature (change in %). 14 
Statistical Analysis
Medication and Endothelial Function
The use of vasoactive medication had a minimal effect on the test results ( (35) 9 (24) 17 (40) 12 (43) respectively, P=0.03, but not with the other endothelial function tests.
Discussion
In our current study on patients with suspected significant coronary artery disease, BMI was independently and strongly associated with microvascular endothelial dysfunction. Diabetes mellitus, hypertension, hypercholesterolemia, and smoking did not significantly influence endothelial function in this population. In patients with a high BMI, a significant impairment of the hyperemic flow response was found with all 3 microvascular endothelial function tests. Several studies have been published reporting factors influencing endothelial function. However, the outcomes vary significantly, possibly as a result of different study populations, different stimuli used for probing endothelial function, and different methods used for analyzing vascular response. 18, 19 Also several studies showed a high coefficient of variability when performing repeated measurements with EndoPAT on the same day. 20, 21 LDF and DTM have lower coefficients of variability when same-day repeated testing is done. 14, 22 Obese patients, especially those with visceral adiposity, are known to have low-grade inflammation, which can lead to insulin resistance and type 2 diabetes mellitus. 23 Only recently perivascular adipose tissue, which is increased in obesity, has been shown to be of influence in microvascular function. In addition to the lamina intima, media, and adventitia, it is described as the fourth vessel wall layer, and this tissue has an important role in vasomotor regulation by excreting vasoactive adipocytokines. 24 Under normal circumstances, perivascular adipose tissue functions in a paracrine fashion, directly reducing smooth muscle tone 25 and enhancing insulin-dependent vasodilatation. In obese mice, perivascular adipose tissue-dependent vascular relaxation is attenuated, partly as a result of reduced nitric oxide (NO) bioavailability. 26, 27 Change of perivascular adipose tissue function in healthy obese women has been shown to lead to a decreased insulin-dependent microvascular vasodilator capacity, 28 which in turn is linked to NO-dependent vasodilatation. 29 In 1 study, obese patients had a significant lower microvascular hyperemic response to postocclusive reactive hyperemia compared with a healthy control population. This difference diminished after lowering the BMI by gastric bypass surgery, both in patients with and without type 2 diabetes mellitus. 30 In line with these results, our study showed that a high BMI is an independent predictor of reduced endothelial function in patients with suspected and established vascular disease. Importantly, we have found that the relationship between BMI and microvascular endothelial dysfunction remains, even taking in account treated obesity-related cardiometabolic risk factors such as hypertension, hypercholesterolemia, and diabetes mellitus. Not only is increased BMI a plausible cause for endothelial dysfunction, but it has also been posed that endothelial dysfunction itself may initiate other features of metabolic syndrome. There is evidence that microvascular dysfunction precedes insulin resistance, type 2 diabetes mellitus, and high blood pressure. [31] [32] [33] [34] The weak correlation between the 3 tests in our study may reflect the different entities of microvascular function. While the peripheral arterial tonometry output is primarily determined by the effect of total increase of pulsatile arterial digital blood volume (dilatation of arterioles), the output of the other 2 tests reflects changes in the capillary blood flow of the outer layer of the skin. 35 The temperature of the skin is highly dependent on skin capillary blood volume and might rather reflect the (temperature) exchange capacity of the superficially located capillary endothelium than blood (cell) flow in Our population was small, heterogeneous, and consisted of patients with and without established CVD. It is possible that treatment of vascular disease and risk factors might have influenced endothelial function. Indeed, most patients received vasoactive medication at the time of the measurements. However, the independent relation of BMI with endothelium-dependent vasodilatation supports the hypothesis that microvascular dysfunction is not reversed by treatment of risk factors in obese patients and remains influenced by adipose tissue, even in patients without diabetes mellitus or other metabolic risk factors. 28 The sample size may have been too small to detect differences in endothelial function in patients with and without metabolic risk factors. In particular, comparison between groups based on risk factors with low prevalence may have been limited by low power. For this reason we also reported standardized regression coefficients that can be used to judge the strength of association of risk factors with endothelium-dependent vasodilatation. Again BMI and to a lesser extent diabetes mellitus and hypertension showed small-to-moderate associations with endotheliumdependent vasodilatation that were consistent for the 3 tests used. In addition, there have been several small studies that found a significant influence of metabolic factors on endothelial function. 36, 37 In our population, metabolic risk factors were well treated, potentially obscuring the relation between these risk factors and endothelial function. In patients without established CVD, microvascular dysfunction potentially indicates a very early stage of atherosclerosis and it might be the first sign of cardiovascular risk, even before the appearance of classical metabolic risk factors. Especially in so-called metabolically healthy obese persons, microvascular function testing might identify subjects at risk for development of metabolic risk factors and cardiovascular events. These apparently healthy persons may benefit more from early (lifestyle) intervention. Such intervention studies are mandated and will shed light on the value of endothelial function testing in addition to known metabolic risk factors.
Conclusion
High BMI is associated with endothelial dysfunction in patients with suspected coronary artery disease, even in patients with treated metabolic risk factors.
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